| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 07/07/2011 | WO2011082345A2 Compositions and methods for cancer management using antibodies binding to nucleotide salvage pathway enzymes and complexes thereof |
| 07/07/2011 | WO2011079864A1 Method and kit for quantifying risk predictor |
| 07/07/2011 | WO2011003818A3 Manganese comprising contrast agent for diagnosis of hepatic fibrosis and cirrhosis |
| 07/07/2011 | US20110167506 Method for evaluation of developmental toxicity |
| 07/07/2011 | US20110167505 GFATS As Modifiers of the AXIN Pathway and Methods of Use |
| 07/07/2011 | US20110166320 Somatostatin analogues |
| 07/07/2011 | US20110165653 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities |
| 07/07/2011 | US20110165584 Variable Lymphocyte Receptors, Related Polypeptides and Nucleic Acids and Uses Thereof |
| 07/07/2011 | US20110165160 Neutrokine-alpha and neutrokine-alpha splice variant |
| 07/07/2011 | US20110165144 Methods for treating rheumatoid arthritis |
| 07/07/2011 | US20110165091 Method and composition for delivery of medicants to animals |
| 07/07/2011 | US20110165090 Method and composition for delivery of medicants to animals |
| 07/07/2011 | US20110165089 Complex Compound and MRI Probe Made of Same |
| 07/07/2011 | US20110165088 Nanobubbles useful as an ultrasonic contrast agent for lymphatic system |
| 07/07/2011 | US20110165087 Targeted delivery of imaging probes for in vivo cellular imaging |
| 07/07/2011 | US20110165085 Tumor selective fluorescent staining agent |
| 07/07/2011 | US20110165084 Vivo detection of phospholipase activation |
| 07/07/2011 | US20110165083 Peptides that home to tumor lymphatic vasculature and methods of using same |
| 07/07/2011 | US20110165082 Method for determining the anti-tumor efficacy of monoclonal antibodies |
| 07/07/2011 | US20110165081 Psma antibodies and uses thereof |
| 07/07/2011 | US20110165080 Monoclonal antibodies and their use |
| 07/07/2011 | US20110165079 Peptide for transmigration across blood brain barrier and delivery systems comprising the same |
| 07/07/2011 | US20110165078 Specific binding members against synaptophysin |
| 07/07/2011 | US20110165077 In vivo tumor targeting and spectroscopic detection with surface enhanced raman nanoparticle tags |
| 07/07/2011 | US20110165075 Integrin targeting agents and in-vivo and in-vitro imaging methods using the same |
| 07/07/2011 | US20110165074 Chelating amphiphilic polymers |
| 07/07/2011 | US20110165072 Detection of Early-Stage Pancreatic Adenocarcinoma |
| 07/07/2011 | US20110165067 Carbohydrate functionalized catanionic surfactant vesicles for drug delivery |
| 07/07/2011 | US20110165066 Interleukin-13 binding proteins |
| 07/07/2011 | US20110165065 Means for the detection and treatment of prostate cells |
| 07/07/2011 | US20110165064 Methods and compositions related to clot-binding compounds |
| 07/07/2011 | US20110165063 Il-1 binding proteins |
| 07/07/2011 | CA2786084A1 Method and kit for quantifying risk predictor |
| 07/06/2011 | EP2341346A2 Methods of high-throughput screening for internalizing antibodies and metal-chelating liposomes |
| 07/06/2011 | EP2341060A1 Molecules with extended half-lives, compositions and uses thereof |
| 07/06/2011 | EP2340843A1 Methods and compositions to treat myocardial conditions |
| 07/06/2011 | EP2340262A1 Formulations targeting igfbp7 for diagnosis and therapy of cancer |
| 07/06/2011 | EP2340051A1 Drug carrier providing mri contrast enhancement |
| 07/06/2011 | EP2340041A2 Porphyrazine optical and dual optical/mr contrast and therapeutic agents |
| 07/06/2011 | EP2339951A1 Device, method and kit for in vivo detection of a biomarker |
| 07/06/2011 | EP1673473B1 Use of genetic polymorphisms that associate with efficacy of treatment of inflammatory disease |
| 07/06/2011 | CN1879896B Paramagnetic metal manganese doped multi-complex as magnetic resonance imaging contrast agent |
| 07/06/2011 | CN102114249A Oxygen carrying coronary contrast medium and preparation method thereof |
| 07/05/2011 | CA2474386C Integrin targeted imaging agents |
| 07/05/2011 | CA2453845C Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy |
| 06/30/2011 | WO2011079317A2 Ultrasound-activated nanoparticles as imaging agents and drug delivery vehicles |
| 06/30/2011 | WO2011077751A1 Composition for labeling tissues of central nervous system, method for labeling tissues of central nervous system, and screening method using the composition for labeling tissues of central nervous system |
| 06/30/2011 | WO2011077733A1 Transnasal labeling composition for tissues of central nervous system, and labeling method and screening method each using the transnasal labeling composition for tissues of central nervous system |
| 06/30/2011 | WO2011076804A2 Method for determining the liver function of a human being by quantitatively measuring the metabolism of substrates |
| 06/30/2011 | WO2011056958A3 Detection of traumatic brain injury |
| 06/30/2011 | WO2011010848A3 Multifunctional nanoparticles for fluorescence, mr and pet images comprising magnetic silica nanoparticles doped with a near-infrared (nir) dye allowing composite imaging of lymph nodes and deep organs, and a method for synthesising the same |
| 06/30/2011 | WO2011008992A3 Peptides whose uptake in cells is controllable |
| 06/30/2011 | US20110160438 Il-17 receptor like molecules and uses thereof |
| 06/30/2011 | US20110158915 Nanoshells with targeted enhancement of magnetic and optical imaging and photothermal therapeutic response |
| 06/30/2011 | US20110158914 Fluorescence image capturing method and apparatus |
| 06/30/2011 | US20110158913 Antisense and pretargeting optical imaging |
| 06/30/2011 | US20110158912 Method and device for determining the severity of a pain disorder |
| 06/30/2011 | US20110158911 Methods for Screening for Antibiotic Compounds |
| 06/30/2011 | US20110158910 Microparticles comprising polymers with thioester bonds |
| 06/30/2011 | US20110158909 Cationic Contrast Agents and Methods of Use Thereof |
| 06/30/2011 | US20110158908 Cyclosporin a-binding protein |
| 06/30/2011 | US20110158906 Targeted block copolymer micelles |
| 06/30/2011 | US20110158905 Dock-and-Lock (DNL) Complexes for Therapeutic and Diagnostic Use |
| 06/30/2011 | US20110158901 Chitosan-based nanoparticles and methods for making and using the same |
| 06/30/2011 | DE102009060317A1 Tracking von Knochenmarkzellen für das Metastasenscreening Tracking of bone marrow cells for metastasis screening |
| 06/30/2011 | CA2785490A1 Method for determining the liver performance of a living organism by themeans of quantitative measuring the metabolization of substrates |
| 06/29/2011 | EP2339343A1 Magnetic particles and method for producing thereof |
| 06/29/2011 | EP2338525A2 Remote detection of substance delivery to cells |
| 06/29/2011 | EP2338487A1 Combination therapy with PARP inhibitors |
| 06/29/2011 | EP2338479A1 Radioactively marked microparticles, method for their manufacture and application thereof |
| 06/29/2011 | EP2337587A1 Imaging agents of fibrotic diseases |
| 06/29/2011 | CN1835769B KIM-1 antagonists and use to modulate immune system |
| 06/29/2011 | CN102112158A Biocompatible polymer and magnetic nanoparticle with biocompatibility |
| 06/29/2011 | CN102112043A Method for determining measured data from stomach of patient |
| 06/29/2011 | CN102107013A Sterile ultrasound gel for invasive ultrasound diagnosis and treatment and preparation method thereof |
| 06/29/2011 | CN102107012A Ultrasound gel |
| 06/29/2011 | CN102107011A Paramagnetic-upconversion luminous composite nanometer particle, preparation method and application thereof |
| 06/29/2011 | CN101440126B Acquisition and use of homing polypeptide with targeting specificity related to tumor and metastases thereof |
| 06/29/2011 | CN101342372B Use of pancreatic lipase associated protein 1 |
| 06/28/2011 | US7968105 Tuberculosis vaccines comprising antigens expressed during the latent infection phase |
| 06/28/2011 | US7968104 Use of neurotoxin therapy for treatment of urologic and related disorders |
| 06/28/2011 | CA2464002C Pacap compositions and methods for tumor imaging and therapy |
| 06/28/2011 | CA2446277C Wrinkle indicator tape strip and method of using the same |
| 06/23/2011 | WO2011074621A1 Mesothelin (msln) antibody and use thereof |
| 06/23/2011 | WO2011073922A1 Magnetite in nanoparticulate form |
| 06/23/2011 | WO2011073411A1 Nanoparticle clusters formed from individual nanoparticles of two or more types |
| 06/23/2011 | WO2011073371A1 Manganese chelates and their use as contrast agents in magnetic resonance imaging (mri) |
| 06/23/2011 | WO2011073340A1 Labelled integrin binders |
| 06/23/2011 | WO2011031955A3 Optical monitoring of leukemia |
| 06/23/2011 | WO2010063403A8 Radioisotope-labeled lysine and ornithine derivatives, their use and processes for their preparation |
| 06/23/2011 | US20110154513 Probe for visualizing neural activity |
| 06/23/2011 | US20110154511 Heparanase deficient non-human mammals |
| 06/23/2011 | US20110150938 Supercrystalline Colloidal Particles and Method of Production |
| 06/23/2011 | US20110150779 Dynamic nuclear polarization enhanced nuclear magnetic resonance of water under ambient conditions |
| 06/23/2011 | US20110150778 Assembly of Gas-Filled Microvesicle With Active Component For Contrast Imaging |
| 06/23/2011 | US20110150777 Magnetic resonance tomography imaging |
| 06/23/2011 | US20110150776 Method for Testing and Treating Delayed Food Allergies |
| 06/23/2011 | US20110150775 Genomic approaches to fetal treatment and diagnosis |
| 06/23/2011 | US20110150774 Screening for modulators of ces1 and/or ces3 for the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea |
| 06/23/2011 | US20110150773 Modulators of acetyl-coenzyme a acyltransferase 1 or 2 in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea |